A 65-year-old Parkinson’s disease patient played the clarinet during brain surgery, allowing surgeons to witness immediate improvement in her hand movements after electrical stimulation was applied.
Amid hundreds of emails, phone calls and messages, Tim Ezell opens up about his absence from FOX 2 News in the morning and ...
There are stories of human smuggling cases coming from Craigslist ads. One from 2023 details a 42-year-old Houston-area man ...
Researchers uncovered a key cellular regulator, PP2A-B55alpha, that controls both the cleanup of damaged mitochondria and the creation of new ones. In Parkinson’s disease models, reducing this ...
Scientists have developed a groundbreaking technique enabling them to visualise tiny brain clusters believed to trigger Parkinson’s disease. Researchers hailed the breakthrough, likening it to "being ...
AbbVie has filed for U.S. Food and Drug Administration approval of tavapadon as an oral treatment for the neurodegenerative disorder Parkinson's disease. AbbVie on Friday said the filing is supported ...
Globally recognized figures Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents a complex set of motor symptoms, including tremors, rigidity, bradykinesia ...
Cell and gene therapies account for 20% of pipeline Parkinson's therapy bemdaneprocel in Phase 3 trial Pharma success urgently needed, says fund manager FRANKFURT, Sept 25 (Reuters) - Bayer's ...
In Cleveland’s humid summer heat, Michal Gostkowski, DO, doesn’t need a jacket. In fall, perhaps a light coat. As winter’s cold bite creeps in, he’ll be sure to bundle up. Just like changing outerwear ...
Trial results could underpin request for regulatory approval Bayer already working on manufacturing network Several other research teams working on similar treatments SAN SEBASTIAN, Spain, Sept 22 ...
Parkinson's Disease affects around a million people in the United States, and that number is on the rise, in part because our population is getting older. Dr. Claire Henchcliffe is the chair of ...
Arrowhead agreed to grant Novartis the licensing rights to its preclinical treatment against neurodegenerative disorders including Parkinson's Disease. Arrowhead will receive an upfront payment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback